Data as of Friday, October 23, 2026From 500 companies’ SEC filings · refreshed twice a day · Send feedback
Sector

Health Care buybacks

50 Health Care companies bought back $84.4B of their own stock in the last twelve months.

Company12 monthsLast quarterShares, 1 yrNet of stock pay
1HCAHCA Healthcare$9.1B$1.6B−9.1%$8.7B
2JNJJohnson & Johnson$7.9B$1.7B+0.8%$6.5B
3MCKMcKesson$6.7B$2.5B−5.0%—
4LLYLilly (Eli)$6.2B$1.6B−0.7%$5.5B
5TMOThermo Fisher Scientific$5.0B$1.0B−1.9%$4.7B
6ISRGIntuitive Surgical$4.6B$3.0B−2.8%$3.8B
7MRKMerck & Co.$4.2B$757M−1.7%$3.3B
8ZTSZoetis$3.6B$584M−6.2%$3.5B
9REGNRegeneron Pharmaceuticals$3.3B$1.2B−2.4%$2.3B
10BDXBecton Dickinson$2.5B$0−4.2%$2.2B
11ELVElevance Health$2.2B$330M−2.7%$1.9B
12VRTXVertex Pharmaceuticals$2.0B$470M−1.4%$1.3B
13UNHUnitedHealth Group$1.6B$1.6B−0.4%$623M
14ABBVAbbVie$1.5B$9M0.0%$529M
15GILDGilead Sciences$1.4B$355M−1.0%$530M
16IQVIQVIA$1.4B$552M−4.3%$1.2B
17CICigna$1.3B$280M−1.6%—
18EWEdwards Lifesciences$1.2B$153M−1.8%$1.0B
19MDTMedtronic$1.2B$267M−0.2%$683M
20IDXXIdexx Laboratories$1.2B$347M−2.1%$1.1B
21DXCMDexcom$1.1B$606M−4.4%$947M
22UHSUniversal Health Services$1.1B$321M−7.8%$979M
23CORCencora$1.0B$1.0B−0.7%$851M
24DHRDanaher Corporation$894M$0−1.0%$565M
25DVADaVita$892M$181M−14.6%$761M
26ABTAbbott Laboratories$793M$180M−0.0%$101M
27MTDMettler Toledo$775M$206M−2.8%$752M
28CAHCardinal Health$758M$0−2.5%$394M
29ZBHZimmer Biomet$751M$251M−2.8%$653M
30HSICHenry Schein$728M$200M−6.7%$689M
31LHLabcorp$702M$354M−2.3%$576M
32RMDResMed$700M$200M−1.3%$596M
33COOCooper Companies (The)$644M$339M−3.3%$578M
34DGXQuest Diagnostics$552M$100M−0.9%$464M
35ILMNIllumina, Inc.$542M$128M−2.5%$276M
36RVTYRevvity$476M$16M−5.0%$451M
37VEEVVeeva Systems$473M$246M−1.6%−$22M
38WSTWest Pharmaceutical Services$454M$157M−1.7%$422M
39AAgilent Technologies$380M$78M−0.7%$249M
40SOLVSolventum$355M$288M−1.1%$188M
41STESteris$340M$116M−0.9%$278M
42PODDInsulet Corporation$330M$0−1.8%$252M
43CRLCharles River Laboratories$324M$116M−2.6%$241M
44VTRSViatris$303M$150M−0.8%$131M
45GEHCGE HealthCare$300M$100M−0.4%$157M
46ALGNAlign Technology$267M$67M−1.5%$88M
47HUMHumana$249M$107M−0.2%$6M
48TECHBio-Techne$42M$42M−0.6%$310,000
49CNCCentene Corporation$35M$4M+0.8%−$201M
50WATWaters Corporation$15M$2M+64.6%*−$58M

No buybacks reported: AMGN, BAX, BIIB, BMY, BSX, CVS, INCY, MRNA, PFE, SYK.